Biogen
BIIB
#857
Rank
ยฃ21.37 B
Marketcap
ยฃ144.80
Share price
0.83%
Change (1 day)
53.40%
Change (1 year)

Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.

EPS for Biogen (BIIB)

EPS in 2026 (TTM): ยฃ6.91

According to Biogen's latest financial reports the company's current EPS (TTM) is ยฃ7.02. In 2025 the company made an earnings per share (EPS) of ยฃ6.63 a decrease over its 2024 EPS that were of ยฃ8.42.

EPS history for Biogen from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)ยฃ6.914.32%
2025ยฃ6.63-21.3%
2024ยฃ8.4239.73%
2023ยฃ6.03-61.74%
2022ยฃ15.75101.25%
2021ยฃ7.83-57.43%
2020ยฃ18.39-22.27%
2019ยฃ23.6545.66%
2018ยฃ16.2481.39%
2017ยฃ8.95-29.62%
2016ยฃ12.7210.28%
2015ยฃ11.5323.65%
2014ยฃ9.3357.94%
2013ยฃ5.9135.92%
2012ยฃ4.3513.53%
2011ยฃ3.83

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ6.56-6.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ0.98-85.99%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
ยฃ1.54-78.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ10.87 54.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ1.92-72.62%๐Ÿ‡ซ๐Ÿ‡ท France
Gilead Sciences
GILD
ยฃ5.14-26.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
ยฃ4.15-40.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-ยฃ37.75-638.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
ยฃ1.55-77.97%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Bio-Rad Laboratories
BIO
ยฃ4.59-34.65%๐Ÿ‡บ๐Ÿ‡ธ USA